Early
tests are planned for a COVID-19 vaccine that can be taken as a pill, with no
need for injections.
Work
is underway to develop a vaccine to prevent the coronavirus, which will not
require injection, as it can be delivered into the body in pill form.
The
first phase of trials of the vaccine on humans by a company called Orax will
begin this year.
The
company expects the clinical trial to begin in June.
Oral
vaccines are being considered as part of the second-generation vaccines, which
will be more widely developed and easier to distribute and use.
There
is no guarantee that the vaccine will be successful after the trial, and even
if it does, it will take up to a year for approval.
According
to a statement issued by the company, people will be able to use such vaccines
at home.
The
statement said the vaccine could be shipped from one country to another in a
common refrigerator and stored at room temperature, making it easier to supply
anywhere in the world.
“We
need to do more research to prove that the oral vaccine is effective,”
said Paul Hunter, a professor of medicine at East Angela University.
“But
such a vaccine can be important for people who are afraid of injecting needles,
and their speed will make the campaign easier,” he added.
He
said that such a vaccine would be able to provide other benefits than vaccines
injected in the arm.
According
to him, injected vaccines are usually the best way to prevent serious illness
but often not the best way to prevent getting sick.
The
disease usually affects the nose and throat, but the vaccine focuses on
preventing the disease in different areas.
The
results of this oral vaccine on animals have not yet been published, but the
company has described them as encouraging, but the results on humans remain the
same, it is not yet possible to say.
Comments